BrainStorm Cell Therapeutics is a biopharmaceutical company developing adult stem cell-based therapies for a variety of neurodegenerative diseases such as amyotrophic lateral sclerosis , multiple sclerosis and Parkinson’s disease . The company’s NurOwnA technology is based on the use of mesenchymal stem cells , engineered ex vivo, to express increased amount of neurotrophic factors .